AL JAZEERA ENGLISH (AJE) Indonesian stockmarket Feed
Dr Reddy’s Laboratories and Brisbane based Alchemia Ltd, finally got an approval to launch the three generic products in USA.
The US Food and Drug Administration (USFDA) sanctioned it. These Fondaparinux Sodium injections will be used for the curing de…
Increasing on several good product releases in the US generics market, the fourth quarter results posted by pharma Major Dr Reddy based in Hyderabad had been welcomed by the stock market. The scrip had increased by 3.29% on the BSE yesterday.
On Wednesday, Dr. Reddy, one of the major pharmacy companies of the country, witnessed a tragedy when nitrogen leaked in one of their units at Bollaram. The leak took the life of 2 innocent employees at the drug manufacturing unit when they inhaled the leaked nitrogen.
The dreaded incident took place in the production block at the ‘clean room’ where the two employees production chemist Chiranjeevi Sreedhar Reddy (38) and a contract worker Deepak Jena (22) were busy handling the process of micronisation of Omeprazole powder.
India’s leading drug maker, Dr Reddy’s Laboratories Ltd on Wednesday announced that it will issue bonus debentures amounting to $116 million to its shareholders.
The company will issue six bonus debentures for every one share held while the coupon rate on the offering will be decided by the board, according to statement filed by the company with the New York stock exchange.
Business News Asia Pacific News
Australia Stock market
